FDA expands data mining contract
Executive Summary
FDA is renewing a contract to allow the Office of Drug Safety to access San Diego-based Premier's database for inpatient drug utilization information. The agency is also awarding a contract that would allow the Division of Pediatric Drug Development to use Premier's pediatric inpatient data. The utilization data provides context for adverse event reports, modeling of drug risk based on usage patterns and calculating reporting rates for inpatient drug use, Premier said. FDA first contracted for access to Premier's inpatient data in 2001; the agency previously used the Child Health Corporation of America database for pediatric information (1"The Pink Sheet" Oct. 22, 2001, p. 9)...
You may also be interested in...
Off-Label Pediatric Drug Use To Be Tracked Through FDA Database Contracts
Off-label drug use in pediatric patients will be tracked under FDA contracts for longitudinal prescription data.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.